News
GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, swelling that can be caused by cancer treatment.
Trump on Tuesday said his administration will be announcing a “major” tariff on pharmaceuticals “very shortly.” ...
Some neurologists and a consumer watchdog worry that an Eli Lilly–affiliated direct-to-consumer telehealth platform for ...
Trump on Tuesday said his administration will be announcing a “major” tariff on pharmaceuticals “very shortly.” ...
A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...
UVA professor Dr. Christopher Kramer explains how a new Eli Lilly drug may cut a significant heart attack risk factor by 95%.
Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...
Eli Lilly & Co.’s shares fell Monday morning after the Trump administration spiked a plan late last week to pay for obesity drugs for Medicare patients.
After CMS excluded a Biden administration proposal for CMS to cover anti-obesity medications proposal from the final contract year 2026 ...
To what extent will health clinics go to keep selling in-demand weight-loss drugs now that the FDA has outlawed cheaper ...
The drugmaker accuses Premier Weight Loss of risking patients' health by selling altered, unsterile versions of its ...
About a quarter of people risk heart attacks and strokes because they inherited a kind of cholesterol that statin drugs can’t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results